[1]王 健,林柳兵,沈 莹,等.疏肝和中汤联合雷贝拉唑治疗肝胃郁热型反流性食管炎临床研究*[J].陕西中医,2020,(2):168-171.
 WANG Jian,LIN Liubing,SHEN Ying,et al.Efficacy of Shugan Hezhong decoction combined with rabeprazole in treatment of reflux esophagitis stagnated heat of liver and stomach syndrome[J].,2020,(2):168-171.
点击复制

疏肝和中汤联合雷贝拉唑治疗肝胃郁热型反流性食管炎临床研究*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年2期
页码:
168-171
栏目:
临床研究
出版日期:
2020-02-05

文章信息/Info

Title:
Efficacy of Shugan Hezhong decoction combined with rabeprazole in treatment of reflux esophagitis stagnated heat of liver and stomach syndrome
文章编号:
DOI:〖HT5K〗10.3969/j.issn.10007369.2020.02.008
作者:
王 健林柳兵沈 莹叶 悟孙永顺汤 健李毅平
上海中医药大学附属市中医医院(上海 200071)
Author(s):
WANG JianLIN LiubingSHEN Yinget al.
Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine(Shanghai 200071)
关键词:
反流性食管炎 疏肝和中汤 雷贝拉唑 肝胃郁热证 食管黏膜 胃蛋白酶原I 胃泌素17
Keywords:
Key words Reflux esophagitis Shugan Hezhong decoction Rabeprazole Heat of liver and stomach PGI G-17
分类号:
R571
文献标志码:
A
摘要:
的:探讨疏肝和中汤联合雷贝拉唑治疗肝胃郁热型反流性食管炎患者的疗效。方法:选择68 例肝胃郁热型反流性食管炎患者,随机分为治疗组和对照组,每组34例。对照组给予雷贝拉唑治疗; 治疗组给予疏肝和中汤联合雷贝拉唑治疗,8周为1个疗程,随后观察患者治疗前后的症状积分变化及食管黏膜修复作用,及其对胃蛋白酶原I(PGI)、胃蛋白酶原比值(PGR)、胃泌素17(G-17)水平影响,评价两组药物的临床疗效。结果: 治疗组临床疗效总有效率91.2%; 对照组临床疗效总有效率70.1%,经统计学分析具有统计学意义,治疗组疗效优于对照组(P<0.05)。 中药对改善嘈杂易饥、神疲乏力、抑郁或心烦易怒、口苦咽干、大便秘结等肝胃郁热症状效果优于对照组。 中药组能更好促进食管黏膜修复作用,达到良好效果。 疏肝和中汤联合雷贝拉唑可以降低胃蛋白酶原I(PGI)、胃蛋白酶原比值(PGR)、胃泌素17(G-17)水平。结论:疏肝和中汤联合雷贝拉唑对反流性食管炎肝胃郁热证具有较好的临床疗效。
Abstract:
Objective:To discuss the clinical curative efficacy of Shugan Hezhong decoction combined with rabeprazole to treat reflux esophagitis stagnated heat of liver and stomach syndrome.Methods:To selet 68 outpatient and ward with reflux esophagitis stagnated heat of liverand stomach syndrome that have been with clinic treatment in dept of stomach diseases,divide them into treatment group and control group.Each group contained 34 cases.The control group administered rabeprazole.The treatment group administered Shugan Hezhong decoction combined with rabeprazole.Each group took 8 weeks for a course.Subsequently were observed symptom scores the esophagitis healing under gastroscope and the total effective rate before and after treatment.Results:The clinical efficacy of the treatment group is up to 91.2%,and 70.1% about the control group,indicating that the treatment group better than the control group(P<0.05).Improve patient heatburn,sour regurgitation,retrosternal,belching,pharynx ministry unwell respect to the control group was significant difference(P<0.05).Conclusions:Shugan Hezhong decoction combined with rabeprazole treating reflux esophagitis stagnated heat of liver and stomach syndrome with good clinical efficacy.

参考文献/References:

[1] 李 丹,顾志坚.半夏泻心汤治疗胃食管反流病疗效观察[J].陕西中医,2017,38(7):903-904.
[2] 龙 云,杨 莉,张朝瑞,等.枳术宽中胶囊联合奥美拉唑钠肠溶片治疗老年胃食管反流病的疗效及对食管24小时pH值、生活质量的影响[J].陕西中医,2016,37(4):436-437.
[3] Philip O,Lauren B,Marcelo F.Guidelines for the diagnosis and management of gastroesophageal reflux disease[J].Am J Gastroenterol,2013,108:308-328.
[4] 张声升,李乾构,朱 生,等.胃食管反流病中医诊疗共识意见[J].中医杂志,2010,51(9):844-847.
[5] 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:人民卫生出版社,2002:124-129.
[6] 王敬东,杨阅楼.雷贝拉唑肠溶胶囊联合马来酸曲美布汀治疗胃食管返流性咳嗽的疗效观察[J].中国现代医学杂志,2016,26(20):137-141.
[7] 冯小艳,魏 明,邵明义,等.反流性食管炎患者的中医证型分布规律[J].河南中医,2017,37(8):1402-1404.
[8] 谢 彬.反流性食管炎中医证型分布及其相关因素分析[J].中医临床研究,2017,9(17):18-19.
[9] 吴宜华,葛惠男.左金丸合半夏厚朴汤加减治疗胃食道反流病临床研究[J].中医学报,2016,31(222):1782-1785.
[10] 舒文将,姚昕利,陈宗游,等.中药柴胡的药理研究与临床应用[J].广西科学院学报,2017,33(4):268-273.
[11] 陈志坚,胡 璇,刘国道.香附的化学成分及药理作用研究进展[J].安徽农业科学,2017,45(36): 113-115.
[12] 许姗姗,许 浚,张笑敏,等.常用中药陈皮、枳实和枳壳的研究进展及质量标志物的预测分析[J].中草药,2018,49(1):35-44.
[13] 郑婷婷,李剑霜,徐 斌.旋覆代赭汤合香砂六君子汤联合西药治疗反流性食管炎的疗效观察[J].中国中医药科技,2016,23(6):735-736.
[14] 龚来觐,李 鹤.左金丸抗溃疡活性部位筛选与作用机制研究[J].浙江中医杂志,2017,52(11):850-851.
[15] 戴业佳,王 云,张 雪,等.栀子及其相关复方的质控方法及药代动力学研究进展[J].中国实验方剂学杂志,2017,23(24):208-216.
[16] 洪海洲,刘天易.加味三仁汤对慢性胃炎首次根除幽门螺杆菌失败后的治疗[J].中国实验方剂学杂志,2015,21(23):164-167.
[17] 肖 兰.一氧化氮合酶、白细胞介素-8在不同类型胃食管反流病中的表达及意义[J].陕西医学杂志,2017,46(6):778-790.

相似文献/References:

[1]裴书飞,夏永欣.康复新液联合奥美拉唑治疗Ⅱ~Ⅲ级反流性食管炎效果研究*[J].陕西中医,2019,(1):61.
 PEI Shufei,XIA Yongxin..Effect of omeprazole combined with Kangfuxin liquid on treatment of grade II to grade III reflux esophagitis[J].,2019,(2):61.
[2]李翠莲,刘 霞,刘巧梅.清胃顺气汤治疗小儿气郁型反流性食管炎疗效及对患者PGE2、MOT的影响*[J].陕西中医,2019,(6):781.
[3]姚国召,李志红△.四逆香苏乌贝散治疗反流性食管炎疗效研究*[J].陕西中医,2019,(9):1190.
 YAO Guozhao,LI Zhihong..Clinical observation on treatment of reflux esophagitis with Sini Xiangsu Wubei San[J].,2019,(2):1190.
[4]王三强,许敏光,魏会珍,等.反流性食管炎中医学研究进展*[J].陕西中医,2020,(2):266.
 WANG Sanqiang,XU Minguang,WEI Huizhen,et al.Research progress of reflux esophagitis in traditional Chinese medicine[J].,2020,(2):266.
[5]曹志娟,宋珍珍,向英歌.疏肝和中降逆方治疗反流性食管炎中虚气逆证研究进展[J].陕西中医,2023,(9):1327.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.041]
[6]付 勤,袁爱红,解鸿宇,等.名中医杨骏从气机升降论治反流性食管炎经验[J].陕西中医,2024,(4):541.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.024]
 FU Qin,YUAN Aihong,XIE Hongyu,et al.Yang Jun's experience in treating reflux esophagitis from ascending and descending of qi movement[J].,2024,(2):541.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.024]

备注/Memo

备注/Memo:
*上海市“中医经典病房建设试点”项目[ZY(2018-2020)-FWTX-6007];上海市中医优势病种培育项目(ZYBZ-201711)
更新日期/Last Update: 2020-03-31